Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1010 participants.
Also called NCT02809131
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,010 participants
- Registry
-
NCT02809131
-
- Other papers using this trial's data
- Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02809131. Randomized; no masking; primary purpose prevention. Start 2016-04-01 (actual); primary completion 2021-03-31 (actual). Results posted on 2022-05-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
- Acronym
- ENVELOPE
- Condition
- Sick Sinus Syndrome
- Condition
- Complete Heart Block
- Condition
- Syncope
- Condition
- Chronic Systolic Heart Failure
- Intervention (Drug)
- polymixin/bacitracin
- Intervention (Drug)
- cephalexin, or levofloxacin, or clindamycin
- Intervention (Drug)
- Saline
- Lead sponsor
- Vanderbilt University Medical Center
- Collaborator
- Thomas Jefferson University
- Collaborator
- Cooper Norcross Health
- Collaborator
- Valley Health System
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct02809131- Content hash
9af3b1445865ad0bcbc6327d2802fa8622b638be29e79be68718e211b82963f8